BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24100338)

  • 1. The clinical utility of the combination of T stage and venous invasion to predict survival in patients undergoing surgery for colorectal cancer.
    Roxburgh CS; McMillan DC; Richards CH; Atwan M; Anderson JH; Harvey T; Horgan PG; Foulis AK
    Ann Surg; 2014 Jun; 259(6):1156-65. PubMed ID: 24100338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of perineural invasion in stages II and III colorectal cancer.
    Zhou Y; Wang H; Gong H; Cao M; Zhang G; Wang Y
    Pathol Res Pract; 2015 Nov; 211(11):839-44. PubMed ID: 26429129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Methods to Identify Lymphatic and Blood Vessel Invasion and their Prognostic Value in Patients with Primary Operable Colorectal Cancer.
    Van Wyk HC; Foulis AK; Roxburgh CS; Orange C; Horgan PG; McMillan DC
    Anticancer Res; 2015 Dec; 35(12):6457-63. PubMed ID: 26637856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mural and extramural venous invasion and prognosis in colorectal cancer.
    Gibson KM; Chan C; Chapuis PH; Dent OF; Bokey L
    Dis Colon Rectum; 2014 Aug; 57(8):916-26. PubMed ID: 25003286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor deposit is a poor prognostic indicator for patients who have stage II and III colorectal cancer with fewer than 4 lymph node metastases but not for those with 4 or more.
    Nagayoshi K; Ueki T; Nishioka Y; Manabe T; Mizuuchi Y; Hirahashi M; Oda Y; Tanaka M
    Dis Colon Rectum; 2014 Apr; 57(4):467-74. PubMed ID: 24608303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Objective criteria for the grading of venous invasion in colorectal cancer.
    Sato T; Ueno H; Mochizuki H; Shinto E; Hashiguchi Y; Kajiwara Y; Shimazaki H; Hase K
    Am J Surg Pathol; 2010 Apr; 34(4):454-62. PubMed ID: 20216202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer.
    Hamanaka R; Yokose T; Sakuma Y; Tsuboi M; Ito H; Nakayama H; Yamada K; Masuda R; Iwazaki M
    Diagn Pathol; 2015 Apr; 10():17. PubMed ID: 25884820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intramural and extramural vascular invasion in colorectal cancer: prognostic significance and quality of pathology reporting.
    Betge J; Pollheimer MJ; Lindtner RA; Kornprat P; Schlemmer A; Rehak P; Vieth M; Hoefler G; Langner C
    Cancer; 2012 Feb; 118(3):628-38. PubMed ID: 21751188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative neutrophil to lymphocyte ratio >5 is a prognostic factor for recurrent colorectal cancer.
    Mallappa S; Sinha A; Gupta S; Chadwick SJ
    Colorectal Dis; 2013 Mar; 15(3):323-8. PubMed ID: 22958479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal Cancer, Systemic Inflammation, and Outcome: Staging the Tumor and Staging the Host.
    Park JH; Watt DG; Roxburgh CS; Horgan PG; McMillan DC
    Ann Surg; 2016 Feb; 263(2):326-36. PubMed ID: 25575264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous invasion in colorectal cancer: impact of an elastin stain on detection and interobserver agreement among gastrointestinal and nongastrointestinal pathologists.
    Kirsch R; Messenger DE; Riddell RH; Pollett A; Cook M; Al-Haddad S; Streutker CJ; Divaris DX; Pandit R; Newell KJ; Liu J; Price RG; Smith S; Parfitt JR; Driman DK
    Am J Surg Pathol; 2013 Feb; 37(2):200-10. PubMed ID: 23108018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer.
    Sarli L; Bader G; Iusco D; Salvemini C; Mauro DD; Mazzeo A; Regina G; Roncoroni L
    Eur J Cancer; 2005 Jan; 41(2):272-9. PubMed ID: 15661553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel data-driven prognostic model for staging of colorectal cancer.
    Manilich EA; Kiran RP; Radivoyevitch T; Lavery I; Fazio VW; Remzi FH
    J Am Coll Surg; 2011 Nov; 213(5):579-588, 588.e1-2. PubMed ID: 21925905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy for the perineural invasion of colorectal cancer.
    Suzuki T; Suwa K; Ogawa M; Eto K; Kawahara H; Fujita T; Ikegami M; Yanaga K
    J Surg Res; 2015 Nov; 199(1):84-9. PubMed ID: 25935467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
    Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
    J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomograms for predicting the prognosis of stage IV colorectal cancer after curative resection: a multicenter retrospective study.
    Kawai K; Ishihara S; Yamaguchi H; Sunami E; Kitayama J; Miyata H; Sugihara K; Watanabe T
    Eur J Surg Oncol; 2015 Apr; 41(4):457-65. PubMed ID: 25697470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of lymphatic invasion of colorectal cancer: a single-center analysis of 1,616 patients over 24 years.
    Akagi Y; Adachi Y; Ohchi T; Kinugasa T; Shirouzu K
    Anticancer Res; 2013 Jul; 33(7):2965-70. PubMed ID: 23780987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of perineural invasion in patients with stage II colorectal cancer.
    Huh JW; Kim HR; Kim YJ
    Ann Surg Oncol; 2010 Aug; 17(8):2066-72. PubMed ID: 20182809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of the lymph node ratio in stage IV colorectal cancer patients who have undergone curative resection.
    Ozawa T; Ishihara S; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Hata K; Kawai K; Nozawa H; Kanazawa T; Kazama S; Yamaguchi H; Sunami E; Kitayama J; Watanabe T
    Ann Surg Oncol; 2015 May; 22(5):1513-9. PubMed ID: 25398278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.